Relievant_Logo_RGB.png
Relievant Announces Publication of SMART Trial 24-Month Results
April 24, 2019 09:15 ET | Relievant Medsystems, Inc.
MINNEAPOLIS, April 24, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today...
Relievant_Logo_RGB.png
Relievant Announces Level I INTRACEPT Study Enrollment Stopped Early for Superiority
January 30, 2019 09:00 ET | Relievant Medsystems, Inc.
Intracept® Procedure Demonstrates Highly Significant Treatment Effect vs. Non-Surgical Management MINNEAPOLIS, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical...
Relievant_Logo_RGB.png
Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure
January 08, 2019 09:15 ET | Relievant Medsystems, Inc.
MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced...
Relievant Announces
Relievant Announces First Commercial Intracept Procedures
July 10, 2018 09:15 ET | Relievant Medsystems, Inc.
MINNEAPOLIS, July 10, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today...
UPDATE -- Relievant
UPDATE -- Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
June 26, 2018 10:33 ET | Relievant Medsystems, Inc.
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive...
Relievant Announces
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
June 26, 2018 09:15 ET | Relievant Medsystems, Inc.
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive...
Relievant_Logo_For White Background-01.png
Relievant Appoints Christopher Geyen Chief Financial Officer
March 06, 2018 08:30 ET | Relievant Medsystems, Inc.
SUNNYVALE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically...
Relievant_Logo_For White Background-01.png
Relievant Announces Publication of Positive Outcomes in 12-Month SMART Sham RCT
February 08, 2018 16:03 ET | Relievant Medsystems, Inc.
SUNNYVALE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company that developed the Intracept® Procedure, a minimally invasive and clinically proven...
Relievant_Logo_For White Background-01.png
Relievant Medsystems Announces First Patient Enrollment in the INTRACEPT Clinical Study
October 24, 2017 16:03 ET | Relievant Medsystems, Inc.
SUNNYVALE, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically...
Relievant_Logo_For White Background-01.png
Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical Officer
October 18, 2017 08:30 ET | Relievant Medsystems, Inc.
SUNNYVALE, Calif, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically...